Investors with a lot of money to spend have taken a bullish stance on Hims & Hers Health HIMS.
And retail traders should know.
We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.
Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with HIMS, it often means somebody knows something is about to happen.
So how do we know what these investors just did?
Today, Benzinga's options scanner spotted 8 uncommon options trades for Hims & Hers Health.
This isn't normal.
The overall sentiment of these big-money traders is split between 50% bullish and 37%, bearish.
Out of all of the special options we uncovered, 4 are puts, for a total amount of $184,052, and 4 are calls, for a total amount of $181,905.
Expected Price Movements
Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $24.0 to $35.0 for Hims & Hers Health during the past quarter.
Insights into Volume & Open Interest
Examining the volume and open interest provides crucial insights into stock research. This information is key in gauging liquidity and interest levels for Hims & Hers Health's options at certain strike prices. Below, we present a snapshot of the trends in volume and open interest for calls and puts across Hims & Hers Health's significant trades, within a strike price range of $24.0 to $35.0, over the past month.
Hims & Hers Health Option Activity Analysis: Last 30 Days
Noteworthy Options Activity:
Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Ask | Bid | Price | Strike Price | Total Trade Price | Open Interest | Volume |
---|---|---|---|---|---|---|---|---|---|---|---|
HIMS | CALL | TRADE | BEARISH | 12/20/24 | $5.8 | $5.5 | $5.6 | $24.00 | $56.0K | 6.7K | 102 |
HIMS | CALL | SWEEP | BEARISH | 01/16/26 | $11.1 | $10.7 | $10.7 | $30.00 | $53.5K | 4.1K | 50 |
HIMS | PUT | SWEEP | BULLISH | 12/20/24 | $1.15 | $1.05 | $1.05 | $26.00 | $52.5K | 5.9K | 1.0K |
HIMS | PUT | SWEEP | BULLISH | 12/13/24 | $5.9 | $5.6 | $5.62 | $35.00 | $51.2K | 622 | 90 |
HIMS | CALL | TRADE | NEUTRAL | 01/17/25 | $2.85 | $2.55 | $2.7 | $33.00 | $43.2K | 1.0K | 166 |
About Hims & Hers Health
Hims & Hers Health Inc is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, enabling them to access high-quality medical care for numerous conditions related to mental health, sexual health, dermatology, primary care, and more.
In light of the recent options history for Hims & Hers Health, it's now appropriate to focus on the company itself. We aim to explore its current performance.
Where Is Hims & Hers Health Standing Right Now?
- Currently trading with a volume of 4,772,745, the HIMS's price is down by -1.1%, now at $30.53.
- RSI readings suggest the stock is currently may be approaching overbought.
- Anticipated earnings release is in 75 days.
Expert Opinions on Hims & Hers Health
Over the past month, 3 industry analysts have shared their insights on this stock, proposing an average target price of $28.0.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. Click here for access. * An analyst from Canaccord Genuity persists with their Buy rating on Hims & Hers Health, maintaining a target price of $38. * Reflecting concerns, an analyst from TD Cowen lowers its rating to Buy with a new price target of $28. * An analyst from B of A Securities has revised its rating downward to Underperform, adjusting the price target to $18.
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Hims & Hers Health, Benzinga Pro gives you real-time options trades alerts.
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.